{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:28:42Z","timestamp":1785569322812,"version":"3.56.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.transci.2021.103075","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T11:28:36Z","timestamp":1612524516000},"page":"103075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies"],"prefix":"10.1016","volume":"60","author":[{"given":"Preethi","family":"Jeyaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8743-1801","authenticated-orcid":false,"given":"Narendra","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-9902","authenticated-orcid":false,"given":"Divya","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Bhurani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pronamee","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8235-8588","authenticated-orcid":false,"given":"Rahul","family":"Naithani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103075_bib0005","series-title":"WHO coronavirus disease (COVID-19-19) dashboard","year":"2020"},{"issue":"December 2","key":"10.1016\/j.transci.2021.103075_bib0010","article-title":"Repurposed antiviral drugs for Covid-19 \u2014 interim WHO solidarity trial results","author":"WHO Solidarity Trial Consortium","year":"2020","journal-title":"N Engl J Med"},{"issue":"November 11","key":"10.1016\/j.transci.2021.103075_bib0015","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S2213-2600(19)30199-7","article-title":"Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial","volume":"7","author":"Beigel","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"October 8","key":"10.1016\/j.transci.2021.103075_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Intern Med"},{"issue":"January 1","key":"10.1016\/j.transci.2021.103075_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for ebola virus disease in Guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.transci.2021.103075_bib0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"issue":"September 9","key":"10.1016\/j.transci.2021.103075_bib0035","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.mayocp.2020.06.028","article-title":"Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients","volume":"95","author":"Joyner","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.transci.2021.103075_bib0040","unstructured":"https:\/\/www.mohfw.gov.in\/pdf\/ClinicalManagementProtocolforCOVID-19-1919dated27062020.pdf."},{"issue":"7","key":"10.1016\/j.transci.2021.103075_bib0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","article-title":"Case fatality rate of Cancer patients with COVID-19 in a New York Hospital System","volume":"10","author":"Mehta","year":"2020","journal-title":"Cancer Discov"},{"issue":"11","key":"10.1016\/j.transci.2021.103075_bib0050","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2021.103075_bib0055","series-title":"Clinical management protocol: COVID-19 version 5 [internet]. Mohfw.gov.iN.","author":"Ministry of Health & family Welfare","year":"2020"},{"issue":"October 22","key":"10.1016\/j.transci.2021.103075_bib0060","doi-asserted-by":"crossref","first-page":"m3939","DOI":"10.1136\/bmj.m3939","article-title":"Convalescent plasma in the management of moderate COVID-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2021.103075_bib0065","article-title":"Successful use of COVID-19 convalescent plasma in a patient recently treated for follicular lymphoma","author":"Wright","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"October 3","key":"10.1016\/j.transci.2021.103075_bib0070","article-title":"A 63-year-old woman with a history of non-hodgkin lymphoma with persistent SARS-CoV-2 infection who was seronegative and treated with convalescent plasma","volume":"21","author":"Moore","year":"2020","journal-title":"Am J Case Rep"},{"issue":"October 1","key":"10.1016\/j.transci.2021.103075_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-020-00968-1","article-title":"Bar-Natan M.SEvere COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia","volume":"13","author":"Lancman","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"September","key":"10.1016\/j.transci.2021.103075_bib0080","article-title":"Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia","volume":"24","author":"Shankar","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103075_bib0085","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1002\/cam4.3457","article-title":"Convalescent plasma for the treatment of severe COVID-19 infection in cancer patients","volume":"9","author":"Tremblay","year":"2020","journal-title":"Cancer Med"},{"issue":"September","key":"10.1016\/j.transci.2021.103075_bib0090","article-title":"Convalescent plasma therapy in patients with COVID-19","volume":"19","author":"Altuntas","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103075_bib0095","doi-asserted-by":"crossref","unstructured":"Budhiraja S., Dewan A., Aggarwal R., Singh O., Juneja D., Pathak S. et al. Effectiveness of Convalescent Plasma Therapy in Indian Patients with COVID-19. Available at SSRN: https:\/\/ssrn.com\/abstract=3726179 or https:\/\/doi.org\/10.2139\/ssrn.3726179.","DOI":"10.2139\/ssrn.3726179"},{"issue":"February 2","key":"10.1016\/j.transci.2021.103075_bib0100","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jmv.26404","article-title":"The outcome of COVID-19 in patients with hematological malignancy","volume":"93","author":"Yigenoglu","year":"2021","journal-title":"J Med Virol"},{"issue":"March","key":"10.1016\/j.transci.2021.103075_bib0105","article-title":"AIIMS Hematology Alumni Group. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies","volume":"87","author":"Borah","year":"2021","journal-title":"Blood Cells Mol Dis"},{"issue":"August 6","key":"10.1016\/j.transci.2021.103075_bib0110","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.2020006964","article-title":"Use of convalescent plasma in hospitalized patients with COVID-19: case series","volume":"136","author":"Hegerova","year":"2020","journal-title":"Blood"},{"issue":"August 12","key":"10.1016\/j.transci.2021.103075_bib0115","article-title":"Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience","author":"Joyner","year":"2020","journal-title":"medRxiv"},{"issue":"382","key":"10.1016\/j.transci.2021.103075_bib0120","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:50Z","timestamp":1761468710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1473050221000252"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103075","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103075"}}